Thanks to the generosity of donors and supporters, the Pancreatic Cancer Action Network (PanCAN) is funding 13 research grants, totaling nearly $3 million, in 2021. PanCAN invested $22 million in research in fiscal year 2021, bringing our total research investment to more than $149 million to date, which includes the organization’s Research Grants Program and leading-edge scientific and clinical initiatives.
Grantees were selected through a peer-review process. Seven early-career investigators received Career Development Awards and two investigators received Fellowships to help build their pancreatic cancer research focus. PanCAN also awarded two extensions to previous recipients of PanCAN Precision Medicine Targeted Grants to continue their work toward more effective and personalized treatment options, as well as provided funding for two research projects focused on early detection and improving diversity and equity in understanding pancreatic cancer genetic risk factors.
Please join us in welcoming this year’s grantees:
Early Career Investigator Award Recipients
2021 Pancreatic Cancer Action Network Fellowship, funded by The Francois Wallace Monahan Fund in loving memory of Michael Insel
Victoire Cardot-Ruffino, PhD
Dana-Farber Cancer Institute
Evaluation of Antitumor Immunity in Human Clinical Trials
2021 Pancreatic Cancer Action Network Career Development Award funded by The Jim & Shirley Young Family Foundation
Rohit Chandwani, MD, PhD
Weill Cornell Medicine
Hnf1b Defines an Epigenetic Ontology of Human Pancreatic Cancer
2021 Pancreatic Cancer Action Network Career Development Award made possible by Tilynn Bontrager Steiner in memory of Polly Mast
Robert Eil, MD
Oregon Health & Science University
Targeting an Unrecognized Mechanism of Immune Evasion in Pancreatic Cancer
2021 Pancreatic Cancer Action Network Career Development Award in memory of Skip Viragh
Ralph Francescone, PhD
Fox Chase Cancer Center
Metabolic Link to Immunosuppressive Fibroblasts in Pancreatic Cancer
2021 Pancreatic Cancer Action Network Career Development Award
Aditi Jain, PhD
Thomas Jefferson University
Targeting BARD1 in Pancreatic Ductal Adenocarcinoma
2021 Pancreatic Cancer Action Network Career Development Award in memory of Skip Viragh
John Morris IV, PhD
University of North Carolina at Chapel Hill
Dissecting Malignant Evolution Unleashed by p53 Inactivation in PDAC
2021 Pancreatic Cancer Action Network Career Development Award made possible by Linda E. Amuso in memory of Susan A. Lombardi
Shannon Oda, PhD
Seattle Children’s Research Institute, University of Washington
Developing Engineered Proteins to Enhance Adoptive Cell Therapy of PDA
2021 Pancreatic Cancer Action Network Fellowship, funded by The Francois Wallace Monahan Fund in loving memory of Michael Insel
Charline Ogier, PhD
Fox Chase Cancer Center
Preclinical Evaluation of Netrin-1 Antibody for Treatment of Pancreatic Cancer
2021 Pancreatic Cancer Action Network Career Development Award
Catherine F. Whittington, PhD
Worcester Polytechnic Institute
Fibrosis-mediated Transformation in Pancreatic Cancer Risk Factors In Vitro
Research Project Grant Recipients
Treatment Research Projects
2021 Pancreatic Cancer Action Network Precision Medicine Targeted Grant Extension in memory of Skip Viragh
2017 Pancreatic Cancer Action Network Precision Medicine Targeted Grant in memory of Skip Viragh
Gregory Beatty, MD, PhD
Perelman School of Medicine at the University of Pennsylvania
Multiplex Tissue-based Assays and Analytical Tools for Pancreatic Cancer
2021 Pancreatic Cancer Action Network Precision Medicine Targeted Grant Extension funded by Cheryl and Steve Kole, and Rudy Revak
2017 Pancreatic Cancer Action Network Precision Medicine Targeted Grant funded by 1440 Foundation
Sunil R. Hingorani, MD, PhD
Fred Hutchinson Cancer Research Center
Murine Clinical Trials for the Evaluation of High Priority Therapeutic Targets for Precision Promise
Early Detection Research Projects
2021 Pancreatic Cancer Action Network Research Project
Wansu Chen, PhD, MS
Kaiser Permanente Southern California
Extracting and Validating Symptoms Prior to Pancreatic Cancer Diagnosis from Electronic Health Records (EHR)
2021 Pancreatic Cancer Action Network Research Project
Sapna Syngal, MD, MPH
Dana-Farber Cancer Institute
Racial/ethnic Equity in GENetic Education, Risk Assessment and TEsting (REGENERATE) Study